Hepatitis C Virus
Recent studies by Y.L. Lin and co-authors add new data to hepatitis C virus findings
Published in Hepatitis Weekly, October 13th, 2008
According to recent research published in the Journal of Virology, "Broad, multispecific CD4(+) and CD8(+) T-cell responses to the hepatitis C virus (HCV), as well as virus-cross-neutralizing antibodies, are associated with recovery from acute infection and may also be associated in chronic HCV patients with a favorable response to antiviral treatment. In order to recapitulate all of these responses in an ideal vaccine regimen, we have explored the use of recombinant HCV polypeptides combined with various Th1-type adjuvants and replication-defective alphaviral particles encoding HCV proteins in various prime/boost modalities in BALB/c mice."
"Defective chimeric...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2008-10-13)
More Articles from Hepatitis Weekly
- American Academy of Neurology
Majority of children vaccinated against hepatitis B not at increased risk of MS - University of Rochester Medical Center
Existing anti-obesity drugs may be effective against flu, hepatitis and HIV - University of Texas M. D. Anderson Cancer Center
Hepatitis B exposure may increase risk for pancreatic cancer - World Journal of Gastroenterology
A novel therapy for bleeding gastric varices - World Journal of Gastroenterology
Successful construction of eukaryotic plasmids containing HBV C genotype - Apoptosis
Research data from Chungnam National University update understanding of apoptosis - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
